102706-14-9 Usage
Uses
Used in Pharmaceutical Research:
METHYL 7-METHOXY-2,2-DIPHENYL-1,3-BENZODIOXOLE-5-CARBOXYLATE is used as a building block in pharmaceutical research for the creation of new drugs and biologically active molecules. Its unique structure and properties make it a valuable component in the development of innovative therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, METHYL 7-METHOXY-2,2-DIPHENYL-1,3-BENZODIOXOLE-5-CARBOXYLATE is employed as a key intermediate in the synthesis of complex organic compounds. Its versatility and reactivity contribute to the advancement of chemical reactions and the production of novel organic materials.
Used in Analytical Testing and Research Studies:
METHYL 7-METHOXY-2,2-DIPHENYL-1,3-BENZODIOXOLE-5-CARBOXYLATE is utilized as a reference standard in analytical testing and research studies. Its purity and stability make it an ideal candidate for calibration and quality control in various analytical techniques, ensuring accurate and reliable results in scientific research.
Used in Medical Applications:
METHYL 7-METHOXY-2,2-DIPHENYL-1,3-BENZODIOXOLE-5-CARBOXYLATE is being studied for its potential therapeutic benefits in various medical applications. Its pharmacological properties are under investigation, with the aim of identifying its potential use in treating specific diseases or conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 102706-14-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,7,0 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 102706-14:
(8*1)+(7*0)+(6*2)+(5*7)+(4*0)+(3*6)+(2*1)+(1*4)=79
79 % 10 = 9
So 102706-14-9 is a valid CAS Registry Number.
InChI:InChI=1/C22H18O5/c1-24-18-13-15(21(23)25-2)14-19-20(18)27-22(26-19,16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-14H,1-2H3
102706-14-9Relevant articles and documents
Gallic acid metabolites are markers of black tea intake in humans
Hodgson, Jonathan M.,Morton, Lincoln W.,Puddey, Ian B.,Beilin, Lawrence J.,Croft, Kevin D.
, p. 2276 - 2280 (2000)
Gallic acid is one of the main phenolic components of black tea. The objective of this study was to identify urinary gallic acid metabolites with potential for use as markers of black tea intake. In an initial study, nine compounds, assessed by using gas chromatography-mass spectrometry, were found to increase in concentration in urine after 3 cups of black tea over 3 h. A subsequent study employed a controlled crossover design in which 10 subjects consumed 5 cups per day of black tea or water for 4 weeks in random order. Twenty-four hour urine samples were collected at the end of each period. Of the 9 candidate compounds identified in the initial study, only 3 were present at higher concentrations in urine of all 10 subjects during tea- drinking in comparison to water-drinking periods. These compounds were identified as 4-O-methylgallic acid, 3-O-methylgallic acid, and 3,4-O- dimethylgallic acid, all methyl ether derivatives of gallic acid. It is suggested that these compounds have the potential to be used as markers of black tea intake.
Linker-modified quinoline derivatives targeting HIV-1 integrase: Synthesis and biological activity
Benard, Christophe,Zouhiri, Fatima,Normand-Bayle, Marie,Danet, Michele,Desmaele, Didier,Leh, Herve,Mouscadet, Jean-Francois,Mbemba, Gladys,Thomas, Claire-Marie,Bonnenfant, Sabine,Le Bret, Marc,D'Angelo, Jean
, p. 2473 - 2476 (2007/10/03)
A novel series of HIV-1 integrase inhibitors was synthesized and tested in both in vitro and ex vivo assays. These inhibitors are featured by the presence of a quinoline subunit and an ancillary aromatic ring linked by functionalized spacers such as amide
